Health Economics
At Proven Sciences in Saudi Arabia, our Health Economics and Market Strategy (HEMS) division is dedicated to providing strategic insights and analysis to optimize market entry and adoption of pharmaceutical products, medical devices, and health technologies.



Our comprehensive suite of services includes:
- Real-world evidence (RWE): Leveraging real-world data to assess the economic value and market potential of healthcare interventions in authentic clinical settings.
- Clinical outcomes assessments (CAO): Evaluating the clinical and economic impact of healthcare interventions on patient outcomes and healthcare resource utilization.
- Patient-reported outcomes (PRO): Collecting patient-reported data to measure treatment effectiveness, patient satisfaction, and quality of life outcomes.
- Systematic reviews: Conducting thorough and rigorous reviews of existing literature to synthesize evidence and inform strategic decision-making.
- Meta-analysis: Aggregating and analyzing data from multiple studies to provide robust evidence on the efficacy, safety, and cost-effectiveness of healthcare interventions.
- Clinical studies: Designing and executing clinical trials to generate high-quality evidence on the safety, efficacy, and economic value of new healthcare products.
- Post-marketing studies: Conducting studies post-launch to assess real-world effectiveness, safety, and cost-effectiveness of healthcare products and interventions.
- Observational studies: Analyzing data from routine clinical practice to understand treatment patterns, healthcare utilization, and patient outcomes in real-world settings.
- At Proven Sciences, our HEMS division is committed to partnering with clients to develop and execute tailored market strategies that drive successful market access and maximize the value of their healthcare innovations.